DOC vs JAZZ · P/E 62, rev $2.70B vs P/E 1988, rev $4.07B
Healthpeak Properties Inc (DOC) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Healthpeak Properties Inc (DOC) is a reit - healthcare facilities company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported DOC revenue for 2024-12-31 was $2.70B. Net income was $267.3M. Revenue was up 23.8% from 2023-12-31 to 2024-12-31. DOC currently screens at market cap $13.64B and trailing P/E 61.8.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
DOC currently screens at market cap $13.64B and trailing P/E 61.8. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the DOC and JAZZ stock pages for the full models.
Not investment advice.